Clinical Characteristics, Diagnosis and Management of Patients With Pulmonary Thromboembolism Who are Not Diagnosed in the Acute Phase and Not Classified as Chronic Thromboembolic Pulmonary Hypertension
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Takeshi Nakano, MD*; Kunio Shirato, MD acute episode of PTE. Finally, 23 patients (3.7%) remained unclassified because the participating doctor could not decide what type of PTE best described the patient. All cases were diagnosed between November 2000 and August 2003 in the participating centers in JaSPER listed in Appendix 1. The diagnosis of pulmonary embolism was made either by pulmonary angiogram, computed tomography (CT), or magnetic resonance angiogram, which indicated vessel occlusions or intraluminal filling defects, by lung perfusion scan, which indicated a high probability of pulmonary embolism, by trans-esophageal echocardiogram, which indicated central pulmonary emboli, or by autopsy, which demonstrated any pulmonary emboli. Acute PTE was not been diagnosed before autopsy in 5 patients. Our study used the data from 456 patients with acute PTE, excluding these 5 patients, 92 patients with chronic PTE, and 53 patients with CTEPH. Their clinical characteristics are shown in Table 1 .
All decisions concerning the diagnostic workup, treatment, and cause of death whether from a first acute PTE attack or recurrent PTE were made by the clinicians caring for each patient. The steering committee took care not to influence the management strategy used in the participating hospitals.
Data Acquisition
Complete information on the clinical course and the diagnostic and therapeutic modalities of the patients entering the registry was obtained from a standardized questionnaire sent to the participating centers by the steering committee. Data were collected on (1) the type of PTE (acute PTE, chronic PTE, CTEPH, or unclassified); (2) 30-day mortality after the diagnosis of PTE; (3) clinical symptoms and signs at diagnosis; (4) presence of underlying diseases or predisposing factors for PTE; (5) definitive diagnostic procedures; and (6) treatment. 
Statistical Analysis
Statistical analysis was carried out using SPSS 12.0 (SPSS Inc, Chicago, ILL, USA). All continuous variables were analyzed by Mann-Whitney test and expressed as mean ± standard deviation or median. Categorical data were analyzed by chi-square statistics. Multiple comparisons were performed using Bonferroni's method. All significant tests were two-tailed.
Results

Clinical Characteristics
Patients with CTEPH were the youngest and had the smallest body mass index among the 3 types of PTE. Days from onset of symptoms to diagnosis were shorter in acute PTE, chronic PTE, and CTEPH in this order. The cause of death of the patients with acute PTE was PTE in 76.7%, preexisting disease in 13.3%, and intracranial hemorrhage in 10.0% and 33.3%, 66.7%, and 0.0%, respectively for chronic PTE (p=0.015) ( Table 1) .
Most of the patients with acute PTE had one acute episode. Although half of the cases with either chronic PTE or CTEPH did not have acute episodes, approximately 30% had suffered repeated acute episodes Chest pain, cold sweat and syncope were the most frequent symptoms in acute PTE, whereas dyspnea and hemoptysis were the most frequent in CTEPH ( Table 2) . As risk factors, prolonged immobilization, recent major operation, recent fracture and active cancer were most frequent in acute PTE, whereas chronic heart or respiratory failure was most frequent in chronic PTE. Cerebrovascular disease was present in approximately 15% of chronic PTE, but this ratio was not significant (Table 3) : 33 cases of chronic PTE (35.9%) had chronic heart failure, chronic respiratory failure or cerebrovascular disease.
Shock or cardiopulmonary arrest at diagnosis occurred in 21.8% of acute PTE, 1.1% of chronic PTE, and 1.9% of CTEPH (p<0.001).
Diagnostic Techniques
Pulmonary angiography, perfusion lung scan and ventilation lung scan were used least frequently in acute PTE. D-dimer was examined most frequently in CTEPH and a high concentration (≥0.5 g/ml) was found in 96.0% in acute PTE, 78.9% in chronic PTE, and 72.3% in CTEPH (p<0.001). Deep vein thrombosis (DVT) was assessed in over 80% of each type of PTE (Table 4) .
CT and lower limb venous compression ultrasonography were used for detecting DVT least frequently in acute PTE (Table 5) . Symptoms of DVT were present in 38.5% of acute PTE, 32.1% of chronic PTE, and 27.5% of CTEPH (p=0.21). The actual presence of DVT was 65.2% in acute PTE, 52.4% in chronic PTE, and 48.9% in CTEPH (p=0.02). DVT was examined in 39.9% and 15.2%, and found in 84.6% and 87.5% of cases of acute PTE on the day it was diagnosed or the next day, respectively.
Management
Heparin, thrombolysis and catheter therapy were used most frequently in acute PTE, whereas surgery was chosen most frequently in CTEPH. The surgery in acute PTE and chronic PTE was embolectomy, and that in CTEPH was thromboendarterectomy. Inferior vena cava filters were used in approximately 30% of each type of PTE. In the cases that survived 30 days, warfarin was used in over 80% regardless of the type (Table 6) .
Patients with a high concentration of D-dimer were administered heparin and thrombolytic agents more frequently in CTEPH and chronic PTE cases, but there was no significant difference in chronic PTE (Table 7) . In acute PTE, the median duration of heparin administration was 10 days (Fig 1) . Both urokinase and tissue plasminogen activator (t-PA) were used in 26.4% (71 patients) of cases treated with thrombolytic agents, which means that these combinations were used 37.2% in patients administered urokinase, and 47.7% in those given t-PA. The day of starting these was the same in 70.6% of the cases administered both medicines. There was no significant differences in the duration of urokinase use between cases with and those without t-PA, and the median duration was 6 days (Fig 2) . There were also no significant differences in the duration of t-PA use between cases with and without urokinase, and the median duration was 1 day (Fig 3) .
Discussion
In the present study, we showed that chronic PTE was characterized by (1) different symptoms to those in acute PTE, (2) delayed clinical diagnosis, (3) presence of chronic heart and chronic respiratory failure, (4) lower rate of symptoms similar to those found in acute PTE, and (5) mild to moderate severity of PTE. We also found that the diagnostic and management techniques differed according to the type of PTE.
Clinical Characteristics
There are many studies on typical acute PTE 1,3,5,6,9-11 and CTEPH, [12] [13] [14] [15] but none of cases other than these 2 types. In the present study, cases that could not be categorized into acute PTE or CTEPH and had some chronic factors were defined as chronic PTE and we then compared the clinical characteristics of these 3 types of PTE (acute PTE, chronic PTE and CTEPH). Some investigators have suggested that CTEPH occurs by different mechanisms from those of acute PTE, 14 but another aspect is that neither chronic PTE nor CTEPH was detected in the acute phase. Therefore, to determine the clinical characteristics of chronic PTE and CTEPH it was necessary to clarify why the diagnosis was delayed.
As shown in Table 1 , chronic PTE is not usually accompanied by the sudden appearance of symptoms as in acute PTE and many of the chronic PTE cases had delayed diagnosis. When comparing the 3 types of PTE in terms of the risk, prolonged immobilization, recent major surgery, fracture, and cancer were found most frequently in acute PTE, whereas many patients with chronic PTE had chronic heart or respiratory failure. Therefore, the presence of these preexisting diseases seems to be one of the reasons why the diagnosis for chronic PTE is delayed. Approximately 20% of the chronic PTE cases occurred in hospital, which shows that acute risk factors also contributed to the occurrence of chronic PTE in some cases. The 30-day mortality in chronic PTE was similar to that in acute PTE, but many of the deaths in chronic PTE patients were caused not by PTE itself but by the preexisting disease.
Patients with CTEPH were the youngest and had the lowest body mass index among the 3 types of PTE, which is consistent with the findings of a previous report 15 and may indicate that the mechanisms of CTEPH are different from those for acute PTE. Further studies are needed to confirm this hypothesis. Our data showed that CTEPH comprises a high percentage (8.4%) of PTE cases compared with that in Western countries but was not as high as described previously. 4, 5 Moreover, 50% of the CTEPH patients did not have acute episodes, which suggests that CTEPH did not always follow acute PTE.
As symptoms, dyspnea, chest pain and cold sweat occurred at the lowest rate in chronic PTE, whereas dyspnea was highest in CTEPH, and chest pain, cold sweat and syncope were highest in acute PTE. Delays in the diagnosis of chronic PTE appear to be partly because of the low incidence of the subjective findings of typical acute PTE.
Diagnostic Techniques
The diagnostic techniques were not uniform for the 3 types of PTE and were chosen according to the type of PTE. This difference in diagnostic approach may be related to the severity of PTE and to the need to examine the indication for therapy. For example, pulmonary angiography was performed more frequently in CTEPH because of the definition of the indication for thromboendartectomy. Ventilation and perfusion lung scans were used more in chronic PTE and CTEPH. However, only a few hospitals in Japan can perform a ventilation scan on the day it is ordered. We previously reported that perfusion and ventilation lung scans were chosen in the less severe cases of acute PTE, 6 and because there is more time for diagnosis in cases of There were no statistical differences between the administered periods of t-PA alone and that of t-PA with urokinase (UK) (p=0.79). The median value of t-PA administration was 1 day.
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chronic PTE and CTEPH, lung scans were chosen more frequently for these 2 types of PTE. CT was used in all types of PTE. Technical developments in multidetector row CT have increased its effectiveness for the diagnosis of PTE, and lesions at the subsegmental pulmonary artery can be detected. 16, 17 Therefore, it is expected that CT diagnosis will be used more often.
Though the concentrations of D-dimer were highest in acute PTE, the rate of investigating this parameter was highest in CTEPH. Patients with CTEPH had right ventricular overload, which may be a decision criteria for trying thrombolytic therapy in acute PTE, but in CTEPH, it has to be determined whether the acute thromboembolic factor contributed to the patient's clinical status. That is, the use of D-dimer in patients with CTEPH may not be useful for the diagnosis of PTE but rather for therapeutic selection.
A low rate of assessing DVT is a clinical problem in acute PTE in Japan, 4, 5, 9, 18 and it is found less in patients with acute PTE in Japan than in Western countries. 9, 18 But, in the present study DVT was found in more than 80% when diagnosis was limited to the cases either examined for DVT on the day when acute PTE was diagnosed, or on the next day. This fact shows that examination for DVT early after the acute PTE diagnosis is necessary for accurate estimation of the DVT frequency in Japan. CT and lower limb venous compression ultrasonography are widely used to diagnose DVT 18 and PTE can be diagnosed almost simultaneously.
Management
The management tecnique also differed among the 3 types of PTE. Heparin, thrombolysis and catheter therapy were used more often in acute PTE, and surgery more often in CTEPH. The surgery in CTEPH was thromboendarterectomy and for acute and chronic PTE it was thrombectomy. Inferior vena cava filters and warfarin were used regardless of the type of PTE. The permanent type of filter tended to be used in CTEPH and both temporary and retrievable types were used in acute PTE, but the differences did not reach statistical significance. However, because permanent inferior vena cava filters increase the occurrence of DVT, 19, 20 their selection has to be made carefully. Pulmonary hypertension is thought to be a permanent risk factor for PTE, so the permanent type of filter might be chosen for CTEPH. As for anticoagulation, warfarin was used from the start of therapy without the use of heparin in some cases with chronic PTE and CTEPH.
In acute PTE, urokinase was used with and without t-PA. The duration of urokinase use was 6 days, regardless of the use of t-PA. The duration of t-PA use was 1 day, regardless of the use of urokinase. The Food and Drug Administration in the United States approves the use of only 100 mg t-PA/2 h for acute PTE. 21 In practice, the duration of thrombolytic agent use in Japan differs from that in the USA and varies according to the patient (Figs 2,3) . It should be noted that 25% of the cases in which thrombolysis was used both urokinase and t-PA were administered. The combination is an empirical administration method for decreasing residual thrombosis and improving the quality of life in the long term. Further studies are needed to objectively assess the effectiveness of the combined use of urokinase and t-PA.
When the concentration of D-dimer was 0.5 g/ml or higher in chronic PTE and CTEPH, heparin and thrombolysis were used more often, but the difference was significant only in CTEPH. This suggested that, in cases with CTEPH already known to have right ventricular overload, D-dimer may be a useful tool for deciding whether to use thrombolytic agents.
Conclusion
Many of the cases with chronic PTE did not have typical acute episodes of PTE, nor was their onset defined. The severity of PTE in most cases of chronic PTE was mild to moderate. Dyspnea and chest pain, which are frequently found in acute PTE, were found less frequently in chronic PTE. Besides these findings, the presence of preexisting diseases, including chronic heart and respiratory failure, may contribute to the delayed diagnosis ofn chronic PTE. Perfusion lung scans were used most frequently in chronic PTE and thrombolysis was used less frequently.
